HCA Healthcare (HCA) Price Target Increased to $158.00 by Analysts at Jefferies Financial Group

HCA Healthcare (NYSE:HCA) had its target price lifted by Jefferies Financial Group from $155.00 to $158.00 in a research note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price target suggests a potential upside of 18.02% from the stock’s current price.

Several other equities analysts also recently weighed in on the stock. Citigroup raised their price target on shares of HCA Healthcare from $136.00 to $156.00 and gave the stock a “buy” rating in a research note on Thursday, October 11th. Robert W. Baird raised their price target on shares of HCA Healthcare from $130.00 to $150.00 and gave the stock a “positive” rating in a research note on Thursday, September 20th. Bank of America raised their price target on shares of HCA Healthcare from $125.00 to $135.00 and gave the stock an “underperform” rating in a research note on Tuesday, September 18th. Royal Bank of Canada raised their price target on shares of HCA Healthcare to $150.00 and gave the stock an “outperform” rating in a research note on Monday, September 10th. Finally, Argus raised their price target on shares of HCA Healthcare to $150.00 and gave the stock a “buy” rating in a research note on Friday, September 7th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $140.11.

Shares of NYSE HCA traded down $1.33 during trading on Wednesday, hitting $133.88. The company had a trading volume of 72,677 shares, compared to its average volume of 1,819,015. HCA Healthcare has a fifty-two week low of $74.26 and a fifty-two week high of $141.11. The firm has a market cap of $44.25 billion, a price-to-earnings ratio of 20.38, a price-to-earnings-growth ratio of 1.15 and a beta of 0.50.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. The firm had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the firm posted $1.13 earnings per share. Equities analysts expect that HCA Healthcare will post 9.23 EPS for the current fiscal year.

In other HCA Healthcare news, insider Charles J. Hall sold 34,125 shares of HCA Healthcare stock in a transaction dated Friday, August 3rd. The shares were sold at an average price of $129.93, for a total transaction of $4,433,861.25. Following the transaction, the insider now directly owns 98,124 shares of the company’s stock, valued at $12,749,251.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Victor L. Campbell sold 22,782 shares of HCA Healthcare stock in a transaction dated Friday, August 3rd. The stock was sold at an average price of $127.12, for a total transaction of $2,896,047.84. Following the transaction, the senior vice president now directly owns 202,650 shares in the company, valued at $25,760,868. The disclosure for this sale can be found here. Insiders have sold 63,450 shares of company stock worth $8,179,583 over the last ninety days. 2.80% of the stock is owned by insiders.

A number of hedge funds have recently modified their holdings of HCA. Smithfield Trust Co. raised its stake in shares of HCA Healthcare by 541.9% in the 2nd quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock valued at $102,000 after acquiring an additional 840 shares during the period. Signet Financial Management LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $137,000. Adviser Investments LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $159,000. Bridgeworth LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $173,000. Finally, Hyman Charles D purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $205,000. 70.48% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Why do earnings reports matter?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply